150 related articles for article (PubMed ID: 2129197)
1. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN].
Saida K
Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197
[TBL] [Abstract][Full Text] [Related]
2. Humoral mechanisms in immune neuropathies.
Koski CL
Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory neuropathies.
Hughes RA
Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
[TBL] [Abstract][Full Text] [Related]
4. Effector mechanisms in demyelinating neuropathies.
Hartung HP; Zielasek J; Jung S; Toyka KV
Rev Neurol (Paris); 1996 May; 152(5):320-7. PubMed ID: 8881423
[TBL] [Abstract][Full Text] [Related]
5. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection.
Kusunoki S; Chiba A; Hitoshi S; Takizawa H; Kanazawa I
Muscle Nerve; 1995 Apr; 18(4):409-13. PubMed ID: 7715626
[TBL] [Abstract][Full Text] [Related]
6. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
7. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
Hahn AF
Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of immune-mediated neuropathies.
Rostami AM
Pediatr Res; 1993 Jan; 33(1 Suppl):S90-4. PubMed ID: 8381954
[TBL] [Abstract][Full Text] [Related]
9. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
Brown MJ; Rosen JL; Lisak RP
Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
[TBL] [Abstract][Full Text] [Related]
10. Pathology of inflammatory demyelinating neuropathies.
Prineas JW
Baillieres Clin Neurol; 1994 Apr; 3(1):1-24. PubMed ID: 7921584
[TBL] [Abstract][Full Text] [Related]
11. [A case of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome with positive anti-galactocerebroside (Gal-C) IgM antibody].
Kasuya J; Miyazono T; Takenaga S; Arimura K; Osame M; Kusunoki S
Rinsho Shinkeigaku; 1999 May; 39(5):538-41. PubMed ID: 10424145
[TBL] [Abstract][Full Text] [Related]
12. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis.
Hahn AF; Feasby TE; Wilkie L; Lovgren D
Muscle Nerve; 1993 Nov; 16(11):1174-80. PubMed ID: 7692294
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated demyelination--immunopathological basis for electrophysiological changes.
Saida T; Saida K
Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():56-69. PubMed ID: 6962042
[TBL] [Abstract][Full Text] [Related]
14. Demyelination induced by serum from patients with Guillain-Barré syndrome.
Harrison BM; Hansen LA; Pollard JD; McLeod JG
Ann Neurol; 1984 Feb; 15(2):163-70. PubMed ID: 6703656
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunity in inflammatory autoimmune neuropathies.
Mäurer M; Toyka KV; Gold R
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S7-15. PubMed ID: 12690655
[TBL] [Abstract][Full Text] [Related]
16. [Guillain-Barré syndrome and acute disseminated encephalomyelitis (ADEM)].
Hamaguchi K
Rinsho Shinkeigaku; 1996 Dec; 36(12):1301-7. PubMed ID: 9128388
[TBL] [Abstract][Full Text] [Related]
17. Macrophage recruitment in different models of nerve injury: lysozyme as a marker for active phagocytosis.
Venezie RD; Toews AD; Morell P
J Neurosci Res; 1995 Jan; 40(1):99-107. PubMed ID: 7714930
[TBL] [Abstract][Full Text] [Related]
18. Abnormal serum factors in Guillain-Barré syndrome.
Lisak RP; Brown MJ; Summer AJ
Ital J Neurol Sci; 1983 Sep; 4(3):265-72. PubMed ID: 6358121
[TBL] [Abstract][Full Text] [Related]
19. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
Kusunoki S
Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
